Dr. Cerrada-Gimenez joined Experimentica in 2017 and has played a key role in developing the company’s scientific capabilities and operations. Prior to joining Experimentica, he worked in CRO and biotechnology environments, including Charles River Discovery Research Services and Minoryx Therapeutics, focusing on neuroscience and rare diseases from early preclinical studies through to IND-enabling programs. Dr. Marc Cerrada-Gimenez has 18 peer-reviewed publications across various fields.